The bill aims to establish guidelines for the distribution of opioid antagonists by the Michigan Department of Health and Human Services to individuals and governmental entities, with the goal of reducing opioid-related overdoses in the state. It defines key terms such as "opioid antagonist" and "opioid-related overdose," ensuring clarity in the legislation. The bill emphasizes that if the department provides these medications at no cost, recipients will have the flexibility to select the formulation, delivery device, method of administration, or dosage of the opioid antagonist they receive.

However, this choice is limited by the stipulation that it cannot compromise the department's ability to secure federal funding. The bill includes new legal language to formalize these provisions, indicating a structured approach to addressing the opioid crisis through state-supported initiatives.